First American Bank Invests $1.63 Million in HealthEquity, Inc. $HQY

First American Bank acquired a new position in HealthEquity, Inc. (NASDAQ:HQY) in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 17,233 shares of the company’s stock, valued at approximately $1,633,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Mattson Financial Services LLC acquired a new position in HealthEquity during the 3rd quarter worth $228,000. Institute for Wealth Management LLC. raised its stake in shares of HealthEquity by 112.7% during the third quarter. Institute for Wealth Management LLC. now owns 13,563 shares of the company’s stock valued at $1,285,000 after purchasing an additional 7,187 shares in the last quarter. Three Seasons Wealth LLC acquired a new stake in HealthEquity in the third quarter worth about $349,000. Sowell Financial Services LLC acquired a new position in HealthEquity during the 3rd quarter valued at about $233,000. Finally, CWM LLC increased its stake in HealthEquity by 98.1% during the 3rd quarter. CWM LLC now owns 6,426 shares of the company’s stock valued at $609,000 after buying an additional 3,183 shares during the period. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

HQY opened at $92.78 on Tuesday. The company has a quick ratio of 4.13, a current ratio of 4.13 and a debt-to-equity ratio of 0.46. The firm has a market cap of $7.93 billion, a PE ratio of 42.56, a P/E/G ratio of 1.35 and a beta of 0.18. The business has a fifty day simple moving average of $97.27 and a 200-day simple moving average of $95.66. HealthEquity, Inc. has a fifty-two week low of $74.07 and a fifty-two week high of $116.65.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. The business had revenue of $322.16 million during the quarter, compared to the consensus estimate of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.HealthEquity’s revenue was up 7.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.78 earnings per share. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, equities analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Activity

In related news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 1,781 shares of HealthEquity stock in a transaction that occurred on Tuesday, October 7th. The stock was sold at an average price of $88.21, for a total transaction of $157,102.01. Following the transaction, the executive vice president owned 49,795 shares in the company, valued at approximately $4,392,416.95. The trade was a 3.45% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,240 shares of company stock worth $1,640,164 over the last 90 days. 1.50% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

HQY has been the subject of several recent analyst reports. BTIG Research reiterated a “buy” rating and issued a $130.00 price objective on shares of HealthEquity in a report on Thursday, December 4th. Barclays began coverage on HealthEquity in a research report on Monday, December 8th. They issued an “overweight” rating and a $118.00 target price for the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of HealthEquity in a research report on Wednesday, October 8th. JMP Securities set a $122.00 target price on HealthEquity in a research note on Thursday, December 4th. Finally, Barrington Research reiterated an “outperform” rating and issued a $125.00 price target on shares of HealthEquity in a research report on Thursday, December 4th. Two equities research analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $120.27.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.